Cargando…
Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury
Hypoxic-ischemic (HI) brain injury is one of the main causes of disabilities in term-born infants. It is the result of a deprivation of oxygen and glucose in the neural tissue. As one of the most important causes of brain damage in the newborn period, the neonatal HI event is a devastating condition...
Autores principales: | de Cerio, Felipe Goñi, Lara-Celador, Idoia, Alvarez, Antonia, Hilario, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061821/ https://www.ncbi.nlm.nih.gov/pubmed/24961314 http://dx.doi.org/10.3390/brainsci3010191 |
Ejemplares similares
-
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury
por: Lara-Celador, I., et al.
Publicado: (2013) -
Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010) -
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
por: Duranti, Andrea, et al.
Publicado: (2022) -
The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia
por: Beldarrain, Gorane, et al.
Publicado: (2023) -
Role of Antioxidants in Neonatal Hypoxic–Ischemic Brain Injury: New Therapeutic Approaches
por: Arteaga, Olatz, et al.
Publicado: (2017)